Market Tracker

04/24 7:05am ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

5.24
Data as of Apr 23
 +0.09 / +1.75%
Today’s Change
4.60
Today|||52-Week Range
8.19
-13.67%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close5.15
Today’s open5.19
Day’s range-- - --
Volume47,393
Average volume (3 months)55,949
Market cap$196.6M
Dividend yield--
Data as of 04/23/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
AGTCApplied Genetic Tech...-0.57-4.21%
NNVCNanoViricides Inc-0.16-4.64%
RNNRexahn Pharmaceutica...0.000.00%
BOTABiota Pharmaceutical...-0.41-6.84%
Data as of 04/23/2014

Financials

Last reporting dateMarch 14, 2014
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts